News for 'drug manufacturing'

Jalna Factory Raided For Making Fake Ghee, Rs 13 Lakh Stock Seized

Jalna Factory Raided For Making Fake Ghee, Rs 13 Lakh Stock Seized

Rediff.com4 Jun 2026

The Food and Drug Administration (FDA) raided a factory in Jalna, Maharashtra, seizing over Rs 13 lakh worth of suspected adulterated ghee. The unit was allegedly manufacturing fake ghee using edible oil and synthetic essence. Samples have been sent for analysis, and legal action is pending.

Illegal Mephedrone Factory Discovered in Ratlam Poultry Farm, Four Arrested

Illegal Mephedrone Factory Discovered in Ratlam Poultry Farm, Four Arrested

Rediff.com31 Mar 2026

Police in Ratlam, Madhya Pradesh, have uncovered a mephedrone factory operating under the guise of a poultry farm, arresting four individuals and seizing a significant quantity of the drug.

Lucknow Arrests Uncover Maharashtra Drug Supply Network

Lucknow Arrests Uncover Maharashtra Drug Supply Network

Rediff.com25 Mar 2026

Two individuals have been arrested in Lucknow for their involvement in a drug trafficking case originating in Maharashtra's Palghar district. The accused allegedly supplied narcotics to pubs, hotels, and private parties.

Stringent MCOCA To Target Organised Gutka Trade In Maharashtra

Stringent MCOCA To Target Organised Gutka Trade In Maharashtra

Rediff.com12 Jun 2026

Maharashtra FDA Commissioner Tukaram Mundhe has directed officials to invoke the stringent Maharashtra Control of Organised Crime Act (MCOCA) against gangs involved in the illegal manufacture and sale of gutka and other banned tobacco products. This move aims to treat such activities as serious organised crimes affecting public health, rather than mere regulatory violations, due to the sophisticated nature of the illegal trade.

Stringent MCOCA To Target Organised Gutka Trade In Maharashtra

Stringent MCOCA To Target Organised Gutka Trade In Maharashtra

Rediff.com12 Jun 2026

Maharashtra FDA Commissioner Tukaram Mundhe has directed officials to invoke the stringent Maharashtra Control of Organised Crime Act (MCOCA) against gangs involved in the illegal manufacture and sale of gutka and other banned tobacco products. This move aims to treat such activities as serious organised crimes affecting public health, rather than mere regulatory violations, due to the sophisticated nature of the illegal trade.

Modi calls on states to leverage AI, tackle cyber fraud and prepare for El Nino impact

Modi calls on states to leverage AI, tackle cyber fraud and prepare for El Nino impact

Rediff.com11 Jun 2026

Prime Minister Narendra Modi has urged states to balance the opportunities presented by artificial intelligence with the need to safeguard against social challenges like cyber fraud and drug abuse. He also warned of the risks posed by El Nino conditions, calling for stronger water conservation measures and emphasising the collective resolve towards a 'Viksit Bharat'.

Maharashtra FDA Arrests 33 In Food Adulteration Crackdown

Maharashtra FDA Arrests 33 In Food Adulteration Crackdown

Rediff.com28 May 2026

The Maharashtra Food and Drug Administration (FDA) conducted raids across the state, arresting 33 individuals and sealing 27 establishments for food adulteration, selling banned gutkha, and unhygienic food production.

CDSCO allows immediate lab testing of drugs to speed up approvals

CDSCO allows immediate lab testing of drugs to speed up approvals

Rediff.com27 Feb 2026

The Centre has allowed companies to begin lab testing immediately after filing applications instead of waiting for detailed scrutiny, in a move to expedite approvals for manufacture, or import of new drugs.

India Inc Battles Rising Gulf War Costs

India Inc Battles Rising Gulf War Costs

Rediff.com9 Jun 2026

Companies are already diversifying sourcing, raising prices, and reworking operating models as the disruption drags on.

Dawood Ibrahim Aide Dola In NCB Custody Till May 8

Dawood Ibrahim Aide Dola In NCB Custody Till May 8

Rediff.com30 Apr 2026

Notorious drug trafficker Mohammad Salim Dola, a close aide of fugitive gangster Dawood Ibrahim, has been remanded in the Narcotics Control Bureau's custody until May 8 in connection with a 2023 drugs seizure case.

Obesity Drug Can't Be Advertised Anymore

Obesity Drug Can't Be Advertised Anymore

Rediff.com12 Mar 2026

'Any promotional activity carried out under the pretext of disease awareness, influencer engagement, corporate campaigns, or similar activities that create brand recall/product visibility of the prescription shall also be treated as violations.'

Maharashtra Government Vows Action After Gutkha Mafia Attack

Maharashtra Government Vows Action After Gutkha Mafia Attack

Rediff.com9 Jun 2026

A woman Food Safety Officer was targeted by suspected gutkha mafia operatives during a raid in Maharashtra's Chhatrapati Sambhajinagar district. The incident, where a vehicle attempted to run her over, has led the state government to order strict action against those responsible. FDA Minister Narhari Zirwal condemned the attack and assured full support to the officer, vowing no leniency for assailants of government officials.

Why Shiv Sena MP Milind Deora Is Against Weight-Loss Drugs

Why Shiv Sena MP Milind Deora Is Against Weight-Loss Drugs

Rediff.com9 Apr 2026

'The unregulated marketing has to stop. People are getting recommendations for this from gym trainers, from marriage counsellors -- that is simply unacceptable.' ''There are many ways to lose weight -- eat less, fast, exercise, eat healthy. That is how you lose weight.'

Rajasthan Police Seize Key Mephedrone Precursor, Arrest Two

Rajasthan Police Seize Key Mephedrone Precursor, Arrest Two

Rediff.com8 May 2026

Rajasthan Police's Anti-Narcotics Task Force (ANTF) has arrested two individuals and seized approximately 234 kg of 2-Bromo-4-Methyl Propiophenone, a crucial precursor used in the production of the synthetic drug mephedrone.

Maharashtra FDA Seizes Methanol Linked To Liquor Deaths

Maharashtra FDA Seizes Methanol Linked To Liquor Deaths

Rediff.com30 May 2026

Maharashtra FDA seizes 5,929 kg of toxic methanol from a warehouse in Thane district, allegedly linked to spurious liquor that caused 14 deaths in Pune and Pimpri-Chinchwad.

TN special teams to monitor drug firms after cough syrup deaths

TN special teams to monitor drug firms after cough syrup deaths

Rediff.com17 Oct 2025

Tamil Nadu has formed special teams to monitor drug manufacturers after deaths of infants in Madhya Pradesh were linked to a cough syrup made by a Tamil Nadu-based company. Inspections are being conducted at pharmaceutical firms across the state.

Gurugram Police Uncover Fake Diabetes Injection Racket

Gurugram Police Uncover Fake Diabetes Injection Racket

Rediff.com21 Apr 2026

Authorities in Gurugram have uncovered a racket involving the manufacturing and sale of counterfeit Mounjaro (tirzepatide) injections, used for treating type 2 diabetes and aiding weight loss. Two individuals have been arrested, and a nationwide alert has been issued to detect the fake injections.

Gurugram Busts Racket Making Fake Diabetes Injections

Gurugram Busts Racket Making Fake Diabetes Injections

Rediff.com21 Apr 2026

Authorities in Gurugram have uncovered a racket involved in the manufacturing and sale of fake Mounjaro (tirzepatide) injections, used for treating diabetes and obesity. Two people have been arrested, and a nationwide alert has been issued to trace counterfeit batches.

Jharkhand Police Crackdown: Narcotics, Illicit Liquor Worth Crores Seized

Jharkhand Police Crackdown: Narcotics, Illicit Liquor Worth Crores Seized

Rediff.com11 May 2026

Jharkhand Police seized narcotics and illicit liquor worth over Rs 2.54 crore and arrested seven persons in separate operations across five districts.

Drug manufacturers call for 8% duty cut

Drug manufacturers call for 8% duty cut

Rediff.com18 Mar 2005

Indian Drug Manufacturers Association on Friday demanded reduction in excise duty on drugs and pharmaceutical products to 8 per cent from the current 16 per cent.

India's Space Manufacturing Boom

India's Space Manufacturing Boom

Rediff.com15 Aug 2025

The $1.2 billion in-space manufacturing market is expected to grow and be worth more than $20 billion by 2033.

Cipla's Q4 Revenue Below Estimates, Strategic Launches Crucial for Recovery

Cipla's Q4 Revenue Below Estimates, Strategic Launches Crucial for Recovery

Rediff.com22 May 2026

Pharmaceutical major Cipla reported a 3 per cent year-on-year decline in March quarter revenue to Rs 6,541 crore, with net profit falling 55 per cent to Rs 554.6 crore, missing consensus estimates. Despite strong growth in India and Africa, a significant decline in North American sales impacted overall performance, with the company now focusing on new product launches and regulatory filings to drive future gains.

'If Losing Belly Fat Were As Easy As Eating A Gummy...'

'If Losing Belly Fat Were As Easy As Eating A Gummy...'

Rediff.com4 Jun 2026

'...would obesity still be a global epidemic?'

Rare-Disease, Cancer Drugs Get Cheaper

Rare-Disease, Cancer Drugs Get Cheaper

Rediff.com3 Feb 2026

For patients, the immediate impact is a reduction in the final cost of therapies that often run into lakhs per month.

'El Mencho', Mexico's most wanted drug lord killed in military raid

'El Mencho', Mexico's most wanted drug lord killed in military raid

Rediff.com23 Feb 2026

Mexico is facing widespread violence and travel advisories after the death of drug lord 'El Mencho,' the notorious leader of the Jalisco New Generation Cartel, during a military operation.

Budget 2026 boosts healthcare spend, drugs relief

Budget 2026 boosts healthcare spend, drugs relief

Rediff.com1 Feb 2026

The government on Sunday gave a strong push to upgradation and expansion of healthcare infrastructure, medical education and pharma sector with the Union Budget 2026-27 announcing a slew of steps, including those aimed at making India a global hub for allied healthcare professionals and biopharma manufacturing.

Biocon eyes global insulin leadership as rivals pivot to GLP-1 therapies

Biocon eyes global insulin leadership as rivals pivot to GLP-1 therapies

Rediff.com8 Apr 2026

Biocon aims to become the world's leading insulin company, capitalising on larger pharmaceutical rivals' strategic shift towards newer, high-margin GLP-1 diabetes therapies. The company plans to expand its insulin presence across 80 markets, focusing on value maximisation and addressing the indispensable need for insulin, particularly for Type-1 and late-stage Type-2 diabetics.

AI is fast becoming central to how drugs will be discovered

AI is fast becoming central to how drugs will be discovered

Rediff.com25 Feb 2026

Artificial intelligence (AI) is no longer a side conversation for Indian pharma. It is fast becoming central to how drugs will be discovered, made, and supplied. Along with that shift comes a sharper focus on innovation, on the one hand, and quality and trust, on the other.

5 killed in explosions at Tarapur drug manufacturing unit

5 killed in explosions at Tarapur drug manufacturing unit

Rediff.com22 Mar 2013

Explosions in seven reactors at a reputed bulk drug manufacturing company in Tarapur MIDC industrial estate on Friday afternoon killed five of its employees and injured 18 others.

Biocon launches diabetes & obesity drugs in Netherlands

Biocon launches diabetes & obesity drugs in Netherlands

Rediff.com16 Dec 2025

Biocon Limited has launched its GLP-1 peptide, liraglutide, for the treatment of diabetes and obesity in the Netherlands, as the biopharmaceutical firm positions itself as a global player in the fast-growing diabetes and obesity market currently dominated by the likes of Novo Nordisk and Eli Lilly.

Canada first G7 nation to okay Dr Reddy's generic version of semaglutide

Canada first G7 nation to okay Dr Reddy's generic version of semaglutide

Rediff.com30 Apr 2026

Dr Reddy's Laboratories has received approval from Health Canada to sell a generic version of the diabetes drug semaglutide, making it the first company to get market authorisation for a generic semaglutide injection in Canada and the first in a G7 country.

India, New Zealand sign FTA to boost trade, investment

India, New Zealand sign FTA to boost trade, investment

Rediff.com27 Apr 2026

India and New Zealand have signed a comprehensive Free Trade Agreement (FTA) aimed at significantly boosting bilateral commerce and investments, providing duty-free access for 100 per cent of India's exports to New Zealand and securing duty-free inputs for India's manufacturing sector.

Two- and Three-wheeler EV Startups Petition PM For PLI Scheme Inclusion

Two- and Three-wheeler EV Startups Petition PM For PLI Scheme Inclusion

Rediff.com25 May 2026

India's home-grown EV startups say the government's auto PLI scheme is helping big players while shutting out innovators building electric two- and three-wheelers from scratch.

HC allows Zydus to sell generic version of cancer drug nivolumab

HC allows Zydus to sell generic version of cancer drug nivolumab

Rediff.com13 Jan 2026

Delhi High Court has cleared the way for Zydus Lifesciences to proceed with the sale of its version of the cancer drug nivolumab in India. nivolumab is used to treat several types of cancer by activating the body's immune system to target carcinogenic cells.

Govt to Monitor Non-Essential Drug Prices

Govt to Monitor Non-Essential Drug Prices

Rediff.com28 Jul 2025

The National Pharmaceutical Pricing Authority will monitor how companies are increasing prices of non-scheduled drugs.

'14+ Anti-Obesity Drugs In The Pipeline'

'14+ Anti-Obesity Drugs In The Pipeline'

Rediff.com13 Dec 2025

The semaglutide patent expiry next year could unleash a wave of generic versions from Indian drugmakers, with prices expected to go lower -- at least 80 per cent.

17 cancer drugs to become cheaper as FM announces 'trust-based' customs regime

17 cancer drugs to become cheaper as FM announces 'trust-based' customs regime

Rediff.com1 Feb 2026

Sitharaman in her budget speech said that the customs proposal "aim to further simplify the tariff structure, support domestic manufacturing, promote export competitiveness, and correct inversion in duty".

Cough syrup deaths: Pharma co to face criminal action

Cough syrup deaths: Pharma co to face criminal action

Rediff.com8 Oct 2025

Tamil Nadu Government will take criminal action against a drug manufacturer, whose cough syrup has been banned in the wake of children's deaths in Madhya Pradesh, state minister Ma Subramanian said here on Wednesday.

Semaglutide Ruling Sparks Generic Pharma Boom

Semaglutide Ruling Sparks Generic Pharma Boom

Rediff.com24 Mar 2026

At the heart of this debate is Section 3(d) of the Patents Act, a safeguard designed to prevent drugmakers from extending monopoly protection through trivial modifications to existing medicines.

US Senator warns against poor-quality drugs from India

US Senator warns against poor-quality drugs from India

Rediff.com17 Oct 2025

United States Senator Jim Banks has urged the Food and Drug Administration (FDA) to step up inspections of overseas pharmaceutical manufacturing facilities, expressing concern over poor-quality drugs being imported from countries like India and China.